These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8741710)

  • 1. [Drug-resistance patterns of clinical isolates of Pseudomonas aeruginosa in regard to their lipopolysaccharide-chain sizes].
    Hasegawa M; Kobayashi I; Saika T; Nishida M
    Kansenshogaku Zasshi; 1996 Jun; 70(6):605-12. PubMed ID: 8741710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gentamicin-induced alteration in drug susceptibility and lipopolysaccharide-composition of Pseudomonas aeruginosa isolates].
    Hasegawa M; Kobayashi I; Saika T; Nishida M
    Kansenshogaku Zasshi; 1997 Mar; 71(3):199-206. PubMed ID: 9128003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heterogeneity of lipopolysaccharide chain size of Pseudomonas aeruginosa isolated from different clinical sources--with reference to gentamicin-susceptibility and serotype].
    Hasegawa M; Kobayashi I; Saika T; Nishida M
    Kansenshogaku Zasshi; 1995 Jul; 69(7):811-7. PubMed ID: 7561252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ionic binding of 3H-gentamicin and short-term bactericidal activity of gentamicin against Pseudomonas aeruginosa isolates differing in lipopolysaccharide structure].
    Saika T; Hasegawa M; Kobayashi I; Nishida M
    Kansenshogaku Zasshi; 1998 Feb; 72(2):97-104. PubMed ID: 9545684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistance patterns of clinical isolates of Pseudomonas aeruginosa with reference to their lipopolysaccharide compositions.
    Hasegawa M; Kobayashi I; Saika T; Nishida M
    Chemotherapy; 1997; 43(5):323-31. PubMed ID: 9309365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
    Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa: evidence for the involvement of lipopolysaccharide in determining outer membrane permeability to carbenicillin and gentamicin.
    Shearer BG; Legakis NJ
    J Infect Dis; 1985 Aug; 152(2):351-5. PubMed ID: 3928770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran.
    Ranjbar R; Owlia P; Saderi H; Mansouri S; Jonaidi-Jafari N; Izadi M; Farshad S; Arjomandzadegan M
    Acta Med Iran; 2011; 49(10):675-9. PubMed ID: 22071644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF; El-Domany RA; Zaki S; Ashour HM
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa.
    Bryan LE; O'Hara K; Wong S
    Antimicrob Agents Chemother; 1984 Aug; 26(2):250-5. PubMed ID: 6207771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
    Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
    J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Pseudomonas aeruginosa strains isolated from hospitalized children.
    Patzer J; Walkiewicz R; Dzierzanowska D
    J Antimicrob Chemother; 1986 Jul; 18(1):45-9. PubMed ID: 3093444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
    Triantafilo V; Fica A; Silva M; Thompson L
    Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic binding of 3H-gentamicin and short-time bactericidal activity of gentamicin against Pseudomonas aeruginosa isolates with different lipopolysaccharide structures.
    Saika T; Hasegawa M; Kobayashi I; Nishida M
    Chemotherapy; 1999; 45(4):296-302. PubMed ID: 10394013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of acquired drug-resistant genes and strains relationship in
    Fan YF; Cui SY; Zhang C; Xu XM
    Zhonghua Shao Shang Za Zhi; 2018 Feb; 34(2):83-87. PubMed ID: 29973025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.